TLPH
HealthcareTalphera, Inc.
$1.23
+$0.07 (+6.03%)
Jan 5, 2026
Price History (1Y)
Analysis
Talphera, Inc. is a healthcare company operating in the drug manufacturers - specialty & generic industry within the sector of Healthcare. The company has a market capitalization of $57.33M and employs 13 individuals. From a financial perspective, Talphera, Inc.'s profitability metrics are negative across the board. The gross margin stands at 0.0%, while operating and profit margins are -342200.0% and 0.0%, respectively. Net income over the trailing twelve months (TTM) is -$12,461,000. Additionally, free cash flow has been negative, totaling $-6,503,875 over the same period. The company's balance sheet shows a debt-to-equity ratio of 33.89 and a current ratio of 6.83. The valuation context for Talphera, Inc. is characterized by a negative forward price to earnings (P/E) ratio of -4.24, a price to book ratio of 2.92, and a price to sales ratio of 2047.49. The company's cash reserves stand at $21.29M, while debt totals $6.50M.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Talphera, Inc.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Visit website →Key Statistics
- Market Cap
- $57.33M
- P/E Ratio
- N/A
- 52-Week High
- $1.57
- 52-Week Low
- $0.38
- Avg Volume
- 393.71K
- Beta
- 0.30
Company Info
- Exchange
- NCM
- Country
- United States
- Employees
- 13